Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>IEHC announced $6.5M in orders supporting the APKWS program.</li>
<li>This brings its backlog to $45M, nearly tripling YoY.</li>
<li>Last month, IEHC reported Q1 financials that largely beat our estimates including revenue of $10.0M (+59% YoY) and EBITDA of $0.9M (9% margin) compared to negative levels in Q1/26.</li>
</ul>


IEHC announced $6.5M in orders supporting the APKWS program.
This brings its backlog to $45M, nearly tripling YoY.
Last month, IEHC reported Q1 financials that largely beat our estimates including revenue of $10.0M (+59% YoY) and EBITDA of $0.9M (9% margin) compared to negative levels in Q1/26.


IEHC: Increasing Target Price on $6.5M in New Orders

IEH Corp

IEHC: Increasing Target Price on $6.5M in New Orders